In 2024, the forecasted peptic ulcer mortality rate in the U.S. stands at 1.1 deaths per hundred thousand men, reflecting a stable trend into 2025 with a slight reduction to 1.0. This rate remains consistent through 2026 and 2027, before decreasing further to 0.9 by 2028. Compared to 2023, the data suggests a continuing decline in mortality rates, indicating improvements in healthcare and treatment efficacy. The year-over-year change from 2024 to 2025 shows a decrease of approximately 9.1%, while the compound annual growth rate from 2024 through 2028 indicates a stabilization to declining pattern.
Looking forward, advancements in medical treatment, enhanced awareness, and preventative strategies for peptic ulcers will be crucial. Monitoring emerging treatments such as individualized medicine and antibiotic resistance dynamics will be key as healthcare systems strive to maintain and improve the declining trend in mortality rates.
